Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Coronary CT Angiography Noninvasively Detects Coronary Artery Disease

By HospiMedica International staff writers
Posted on 06 Sep 2012
Among patients with suspected or known coronary artery disease, use of a screening test that utilizes computational fluid dynamics to draw on specific data from computed tomographic (CT) angiography imaging demonstrated improved diagnostic accuracy vs. More...
CT angiography alone for the diagnosis of ischemia.

The results from the new study were published online August 26, 2012, in the Journal of the American Medical Association (JAMA). The study was released early to coincide with its presentation at the European Society of Cardiology Congress, held in Munich (Germany), August 25-29, 2012.

“Coronary computed tomographic angiography is a noninvasive anatomic test for diagnosis of coronary stenosis [narrowing of a blood vessel] that does not determine whether a stenosis causes ischemia [inadequate blood supply]. In contrast, fractional flow reserve [FFR] is a physiologic measure of coronary stenosis expressing the amount of coronary flow still attainable despite the presence of a stenosis, but it requires an invasive procedure. Noninvasive FFR computed from CT [FFRCT] is a novel method for determining the physiologic significance of coronary artery disease [CAD], but its ability to identify ischemia has not been adequately examined to date,” according to the article.

James K. Min, MD, from the Cedars-Sinai Heart Institute (Los Angeles, CA, USA) and colleagues conducted a study to assess the performance of noninvasive FFRCT compared with an invasive FFR reference standard for diagnosis of ischemia. The study included 252 patients with suspected or known CAD from 17 centers in five countries who underwent CT, invasive coronary angiography (ICA), FFR, and FFRCT between October 2010 and October 2011. Approximately 77% of patients had experienced angina within the last month. Ischemia was defined by certain criteria. Anatomically obstructive CAD was defined by a stenosis of 50% or larger on CT and ICA. Among 615 study vessels, 271 had less than 30% stenosis and 101 had at least 90% stenosis.

Among study participants, 137 (54.4%) had an abnormal FFR as determined by ICA. The researchers found that the diagnostic accuracy for FFRCT plus CT was 73%, which did not meet a prespecified primary end point for accuracy (as prespecified based on the lower limit of a calculated 95% confidence interval). By comparison, diagnostic accuracy of CT alone for detecting coronary lesions with stenosis of 50% or greater, was 64%. When comparing FFRCT alone with CT alone for identifying these lesions, FFRCT demonstrated better discrimination.

“On a per-patient basis, diagnostic accuracy, sensitivity, specificity, positive predictive value and negative predictive value of FFRCT plus CT were 73%, 90%, 54%, 67%, and 84%, respectively,” the authors wrote. They noted that the sensitivity and negative predictive value of FFRCT were high, indicating a low rate of false-negative studies. “These diagnostic features of FFRCT may encourage a greater sense of diagnostic certainty that patients who undergo CT who have ischemia are not overlooked, such that clinicians may be confident in not proceeding to invasive angiography in patients with stenoses on CT when FFRCT results are normal.”

Related Links:

Cedars-Sinai Heart Institute




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image

Explainable AI Tool Improves Brain Disorder Screening from 4D fMRI

Functional magnetic resonance imaging (fMRI) captures changes in brain activity over time, but the resulting image sequences can be difficult to analyze. Screening for brain disorders requires assessing... Read more

Critical Care

view channel
Image: Liposomes have long been used for gradual drug delivery, with their composition controlling release speed, potency, duration, and potential toxicity. (Image Credit: iStock)

New Drug Delivery System Extends Release of Local Anesthetic for Weeks

Local anesthetics used for nerve blocks often provide pain relief for only a limited period, while perioperative pain can persist much longer. Extending the duration of a nerve block therefore requires... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.